Postoperative intensity‐modulated radiotherapy in sinonasal carcinoma
- 17 June 2005
- Vol. 104 (1) , 71-82
- https://doi.org/10.1002/cncr.21100
Abstract
BACKGROUND Carcinoma of the paranasal sinuses is rare. Standard therapeutic modalities consist of surgery and radiotherapy (RT). Because of the often advanced stage and the vicinity of optic structures, RT‐induced ocular toxicity is a feared side effect of conventional RT. Intensity‐modulated radiotherapy (IMRT) is a relatively new technique, which is implemented with the hypothesis that, compared with conventional RT, it would result in a lower rate of ocular toxicity for an equal local control (LC). METHODS Between 1998 and 2003, 39 consecutive patients received postoperative irradiation by means of IMRT for an adenocarcinoma (n = 31) or squamous cell carcinoma (n = 8) of the paranasal sinuses (n = 36) or nasal cavity (n = 3). T‐classification was T2 in 41%, T3 in 15%, T4a in 23%, and T4b in 21% of patients. Invasion through the cribriform plate was seen in 11 patients. Orbital invasion was present in 36% of patients. The median delivered dose was 70 gray (Gy) (range, 60–70 Gy). The authors compared the overall survival (OS) and LC of the patients with a historic cohort (HC) (n = 30), treated with conventional or 3‐dimensional conformal RT. RESULTS The median follow‐up was 31 months. The actuarial OS rates were 68% at 2 years and 59% at 4 years. The actuarial LC rates were 73% at 2 years and 68% at 4 years. Invasion through the cribriform plate was a significant prognostic factor for LC and OS, with a median time to local disease recurrence of 7 months if present, and a 2‐year LC rate of 90% if not present. In the comparison between the IMRT and HC groups, no significant differences were found for LC and OS. Acute toxicity was mild. Two patients developed decreased vision after RT. No RT‐induced blindness was observed. CONCLUSIONS Postoperative IMRT for sinonasal carcinoma resulted in good LC, with a low acute toxicity and no RT‐induced blindness. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 24 references indexed in Scilit:
- Paranasal sinus tumors: Peter maccallum cancer institute experienceHead & Neck, 2004
- Three-dimensional conformal radiotherapy for paranasal sinus carcinoma: Clinical results for 25 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Malignant tumors of the nasal cavity and paranasal sinusesHead & Neck, 2002
- Planning and delivering high doses to targets surrounding the spinal cord at the lower neck and upper mediastinal levels: static beam-segmentation technique executed with a multileaf collimatorRadiotherapy and Oncology, 1996
- Cisplatin-Based Neoadjuvant Chemotherapy and Combined Resection for Ethmoid Sinus Adenocarcinoma Reaching and/or Invading the Skull BaseJAMA Otolaryngology–Head & Neck Surgery, 1996
- Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factorsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinusesInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radiation-induced injury to the visual pathwayRadiotherapy and Oncology, 1994
- Ethmoid and upper nasal cavity carcinoma: treatment, results and complicationsRadiotherapy and Oncology, 1990
- Squamous cell carcinoma of the paranasal sinuses: The cleveland clinic experience 1977–1986The Laryngoscope, 1989